Cancer Research CR Mantle  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 344-347, May 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waisman, H. A.
Right arrow Articles by Williams, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waisman, H. A.
Right arrow Articles by Williams, J. N., Jr.

Glutamic Acid Dehydrogenase and Glutamic-oxalacetic Transaminase of Blood in Leukemia and Cancer*

Harry A. Waisman, Carl Monder and J. N. Williams, Jr.

( Sarah A. Workman Pediatric Research Lab., Dept. of Pediatrics, Medical School, and the Dept. of Biochemistry, College of Agriculture, Univ. of Wisconsin, Madison, Wis.)

1. Glutamic acid dehydrogenase was estimated spectrophotometrically in white blood cells from patients with acute, chronic granulocytic, and chronic lymphatic leukemias and cancer. The average values for each of these groups were similar to one another and several times higher than in white blood cells from patients without leukemia or cancer or from "normal" blood donors. Red blood cells and plasma contained no detectable glutamic acid dehydrogenase activity.
2. Glutamic-oxalacetic acid transaminase is present in human white blood cells and plasma as determined by manometric assay. No activity was found in red blood cells.
3. No significant differences were observed in plasma transaminase activity from patients in the classifications studied.
4. White blood cell glutamic-oxalacetic acid transaminase levels were similar in the patients with various forms of leukemia, other diseases, and normal controls.

* Supported in part by grants from the Fairchild Found., Milwaukee, Wis., and the Nutrition Found., Inc., New York, N.Y. Published with the approval of the Director of the Wisconsin Agricultural Experiment Station.

Received 11/23/55.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. WEST and H. J. ZIMMERMAN
Serum Enzymes in Disease: I. Lactic Dehydrogenase and Glutamic Oxalacetic Transaminase in Carcinoma
Arch Intern Med, July 1, 1958; 102(1): 103 - 114.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.